header-logo
MSTP students in the Sahoo lab
Medical Scientist Training Program
Donovan Drouillard

Donovan Drouillard

G3 Student

Faculty Advisor

  • Michael Dwinell, PhD, Microbiology & Immunology

Locations

  • Medical Scientist Training Program

Contact Information

Education

BS, Neuroscience, University of Michigan-Ann Arbor, 2018

Research Interests

Cancer immunotherapy, pancreatic cancer, and precision medicine

Research Experience

Medical College of Wisconsin, 2021-present
Advisor: Michael Dwinell, PhD
Project: The Role of CCR6 in pancreatic cancer and tregs (F30CA291095)

University of Michigan-Ann Arbor, 2016-2018
Advisor: Marina Pasca di Magliano, PhD
Project 1: Determining the role of Beta-1 integrin signaling in providing resistance to MEK inhibition in pancreatic cancer
Project 2: Elucidating the downstream targets of the Hedgehog signaling pathway in pancreatic cancer

University of Michigan-Ann Arbor, 2018-2020
Advisor: Flip Bednar, MD, PhD
Project: Identifying the targets of BMI1 in human pancreatic cancer cell lines 

Publications

Drouillard D, Craig BT, Dwinell MB. Physiology of chemokines in the cancer microenvironment. Am J Physiol Cell Physiol. 2023 Jan 1;324(1):C167-C182. doi: 10.1152/ajpcell.00151.2022. Epub 2022 Nov 1. PMID: 36317799; PMCID: PMC9829481.

AbuEid M, McAllister DM, McOlash L, Harwig MC, Cheng G, Drouillard D, Boyle KA, Hardy M, Zielonka J, Johnson BD, Hill RB, Kalyanaraman B, Dwinell MB. Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression. iScience. 2021 May 25;24(6):102653. doi: 10.1016/j.isci.2021.102653. PMID: 34189432; PMCID: PMC8220235.

Steele NG, Biffi G, Kemp SB, Zhang Y, Drouillard D, et al. Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer. Clin Cancer Res. 2021 Jan 25. doi: 10.1158/1078-0432.CCR-20-3715. Epub ahead of print. PMID: 33495315.

Brannon A 3rd, Drouillard D, Steele N, Schoettle S, Abel EV, Crawford HC, Pasca di Magliano M. Beta 1 integrin signaling mediates pancreatic ductal adenocarcinoma resistance to MEK inhibition. Sci Rep. 2020 Jul 7;10(1):11133. doi: 10.1038/s41598-020-67814-9. PMID: 32636409; PMCID: PMC7340786.

Meeting Abstracts

Drouillard D, Volkman B, and Dwinell MB. Roles for the Chemokine Receptor CCR6 in Pancreatitis and Pancreatic Cancer. American Association of Immunologists 2024, Chicago, IL. AAI Trainee Abstract Award. [Poster and Invited Talk]

Drouillard D and Dwinell MB. CCL20 Recruits Super Suppressor CCR6+ Tregs in Gastrointestinal Malignancies. Midwest Tumor Microenvironment 2024, Madison, WI. [Poster and Invited Talk]

Donovan Drouillard, Gwen Lomberk, Raul Urrutia, Susan Tsai, Brian Volkman, and Michael B. Dwinell. Identifying the receptor for CXCL17 and characterizing its role in pancreatic ductal adenocarcinoma. Autumn Immunology Conference 2022, Chicago, IL. [Poster]

General Interests

Volleyball, running, hiking, disc golf, going to concerts, traveling, and a good Netflix binge. My favorite sports teams are the Detroit Lions and Michigan Wolverines.

© 2025 Medical College of Wisconsin.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination Statement
The Medical College of Wisconsin (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.

Notice of Compliance with Laws and Commitment to Civil Rights
The Medical College of Wisconsin is committed to full compliance with all applicable federal, state, and local laws and regulations in the pursuit of our missions. Consistent with recent federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making. As part of this commitment, we are actively reviewing our policies and materials to ensure they align with federal nondiscrimination obligations.